Jyoti D. Patel on the Progress of Immunotherapy in NSCLC

Jyoti D. Patel, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the progress of immunotherapy as treatment for patients with non-small cell lung cancer.

Jyoti D. Patel, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the progress of immunotherapy as treatment for patients with non-small cell lung cancer (NSCLC). Patel is reporting on data presented at the 2015 annual meeting of the American Society of Clinical Oncology, a gathering of nearly 30,000 oncology professionals in Chicago.

Related Content:

CURE TVImmunotherapyLung Cancer
Evaluating Existing and Future Surgical Options for Early-Stage Lung Cancer
‘Time is of the Essence’ in Decision-Making for Early-Stage Lung Cancer
Expert Addresses Disparities in Lung Cancer Screening, What More Can Be Done